SAN

86.18

+0.87%↑

MRK1

111.9

+1.63%↑

ARGX

801

-0.25%↓

PHIA

23.43

+0.26%↑

ONC.US

347.12

-0.66%↓

SAN

86.18

+0.87%↑

MRK1

111.9

+1.63%↑

ARGX

801

-0.25%↓

PHIA

23.43

+0.26%↑

ONC.US

347.12

-0.66%↓

SAN

86.18

+0.87%↑

MRK1

111.9

+1.63%↑

ARGX

801

-0.25%↓

PHIA

23.43

+0.26%↑

ONC.US

347.12

-0.66%↓

SAN

86.18

+0.87%↑

MRK1

111.9

+1.63%↑

ARGX

801

-0.25%↓

PHIA

23.43

+0.26%↑

ONC.US

347.12

-0.66%↓

SAN

86.18

+0.87%↑

MRK1

111.9

+1.63%↑

ARGX

801

-0.25%↓

PHIA

23.43

+0.26%↑

ONC.US

347.12

-0.66%↓

Kodu・Aktsiate loetelu・Nanobiotix

N
Nanobiotix

Suletud

17.96 -1.54

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

17.28

Max

18.38

Põhinäitajad
By Trading Economics
Sissetulek	-46M
Müük	-21M
Kasumimarginaal	221.361
Töötajad	103
EBITDA	-44M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+26.37% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	25. nov 2025

Turustatistika
By TradingEconomics
Turukapital	943M
Eelmine avamishind	19.5
Eelmine sulgemishind	17.96

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

2.975 / 3.015 Toetus ja vastupanu

Nanobiotix Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. nov 2025, 22:42 UTC

Market Talk

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

21. nov 2025, 21:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

21. nov 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

21. nov 2025, 21:47 UTC

Market Talk

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

21. nov 2025, 21:43 UTC

Market Talk

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

21. nov 2025, 20:18 UTC

Market Talk

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

21. nov 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

21. nov 2025, 19:48 UTC

Market Talk

Precious Metals Fall for the Week -- Market Talk

21. nov 2025, 19:44 UTC

Tulu

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

21. nov 2025, 19:37 UTC

Market Talk

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

21. nov 2025, 19:27 UTC

Market Talk

Tulu

Global Equities Roundup: Market Talk

21. nov 2025, 19:27 UTC

Market Talk

Tulu

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

21. nov 2025, 19:20 UTC

Market Talk

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

21. nov 2025, 18:44 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

21. nov 2025, 18:37 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

21. nov 2025, 18:34 UTC

Market Talk

Tulu

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

21. nov 2025, 18:28 UTC

Tulu

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21. nov 2025, 18:03 UTC

Market Talk

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

21. nov 2025, 17:24 UTC

Market Talk

Global Equities Roundup: Market Talk

21. nov 2025, 17:24 UTC

Market Talk

Intuit Seen on Path to Increase Growth -- Market Talk

21. nov 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

21. nov 2025, 17:05 UTC

Market Talk

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

21. nov 2025, 16:56 UTC

Market Talk

Gold Recovers as Investors Boost Rate-Cut Bets -- Market Talk

21. nov 2025, 16:47 UTC

Market Talk

European Gas-Price Forecast to Decline Further on Expanding LNG Supply -- Market Talk

21. nov 2025, 16:35 UTC

Omandamised, ülevõtmised, äriostud

What Stocks Al Gore's Investment Firm Bought and Sold This Quarter -- Barrons.com

21. nov 2025, 16:09 UTC

Tulu

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21. nov 2025, 15:59 UTC

Market Talk

Canadian Consumers Tapping the Brakes, Still See Resilient -- Market Talk

21. nov 2025, 15:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21. nov 2025, 15:23 UTC

Market Talk

Bank of Canada Not Expected to Be Swayed by Canadian Retail Trade Data -- Market Talk

21. nov 2025, 15:17 UTC

Market Talk

Canadian Consumer Spending Softening, But Could Be Worse -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Nanobiotix Prognoos

Hinnasiht

By TipRanks

26.37% tõus

12 kuu keskmine prognoos

Keskmine 23 EUR 26.37%

Kõrge 25 EUR

Madal 21 EUR

Põhineb 3 Wall Streeti analüütiku instrumendi Nanobiotix 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Nanobiotix aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.975 / 3.015Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.